A randomized, open label, multi-center clinical trial, comparing microbiologic response to linezolid and vancomycin in ventilator-associated pneumonia (VAP) due to methicillin resistant Staphylococcus aureus (MRSA)
Phase of Trial: Phase IV
Latest Information Update: 08 Jun 2010
At a glance
- Drugs Linezolid; Linezolid; Vancomycin
- Indications Methicillin-resistant Staphylococcus aureus infections; Nosocomial pneumonia
- Focus Therapeutic Use
- Sponsors Pfizer
- 08 Jun 2010 Actual end date (Jan 2005) added as reported by ClinicalTrials.gov.
- 03 Jan 2008 New trial record.